Edmonton psychiatry professor aims to treat mental illness with psychedelics through new company

An Edmonton startup company is laying the foundation to be a major player in the growing global medical psychedelic market by studying the drug’s effects on mental health. Dr. Peter Silverstone, interim chair of the department of psychiatry at the University of Alberta, is going public with the plans this week. He aims to use […]
Read More